CAS 936889-68-8

OXA-01

CAS: 936889-68-8

OXA-01 is a monoclonal antibody that targets the protein phosphatase 2A (PP2A), which are enzymes that regulate cell growth. OXA-01 has been shown to be effective in reducing tumor growth and inhibiting angiogenesis, which may contribute to its anti-inflammatory properties. It has also been shown to be more potent than rapamycin, an immunosuppressant drug used in cancer therapy, with less side effects. OXA-01's mechanism of action is still unknown, but it is believed that this drug may inhibit the function of PP2A by binding to a specific site on the enzyme and blocking its activity. The effectiveness of this drug on various cancers, including carcinoma cell lines, has been shown through in vivo analysis.

Formel: C₂₁H₂₀ClN₅O₂

Reinheit: Min. 95%

Molekulargewicht: 409.87 g/mol

Ref: 3D-LMB88968

OXA-01

CAS: 936889-68-8

OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC 50 values of 29 nM and 7 nM, respectively [1]. OXA-01 demonstrates broad anti-tumor activity.

Formel: C₂₁H₂₀ClN₅O₂

Farbe und Form: Solid

Molekulargewicht: 409.87

Ref: TM-T21816